期刊文献+

“碘泵基因”转染胶质瘤细胞后摄碘能力的研究

The study of radioiodide uptake by transfered the sodium/iodide symporter gene into gliomas
下载PDF
导出
摘要 目的:证明转染人类钠碘转运体(hNIS)基因入胶质瘤后,胶质瘤细胞可以摄取放射性碘。方法:使用脂质体转染法利用重组质粒将hNIS基因转染入人胶质瘤细胞系U251中,使胶质瘤细胞获得hNIS基因;经过新霉素抗生素筛选获得稳定表达hNIS的细胞系,然后进行体外摄125I实验及过氯酸盐抑制实验;体外125I反流实验,体外125I内流实验,并绘制时间-每分钟放射性计数曲线。结果:在使用质粒转染hNIS基因到U251细胞中后,成功地获得稳定表达hNIS基因的细胞系hNIS-U251。hNIS-U251细胞系可以摄取碘,而且这种摄碘的功能是由hNIS基因所介导的,转染后的细胞摄碘能力可以提高117倍左右。结论:在细胞系hNIS-U251中,放射性碘元素可以被胶质瘤细胞大量摄取。 Objective: To transfect hNIS gene into human glioma cell lines U251 by recombinant expression plasmids and observe radioiodine intaken by U251. Methods: hNIS gene was transfected into human glioma cell lines U251 by recombinant expression plasmids with lipofectamine 2000-plasmid complexes. The stably expressing hNIS gene cell lines (hNIS-U251)were selected with G418. Subsequently we investigated stably expressing hNIS gene cell lines (hNIS-U251)'s biologic function, including ^125I uptake assay of stably expressing hNIS gene cell lines, ^125I influx-course, ^125I-efflux-course. Results: We transfected hNIS gene into human glioma cell lines by recombinant expression plasmids successfully, and obtained the stably expressing hNIS gene cell lines: hNIS-U251. The hNIS-U251 cell lines could intake radioactive iodide by hNIS gene. The uptakes of ^125I were 117 fold higher in hNIS-U251 cell lines than in U251 cell lines. Conclusion: The stably expressing hNIS gene hNIS-U251 cell lines can intake radioiodine.
出处 《天津医科大学学报》 2008年第4期426-429,共4页 Journal of Tianjin Medical University
基金 天津市应用基础及前沿技术研究计划资助(08JC2DJC23900)
关键词 人类钠碘转运体 胶质瘤 转染 基因治疗 Human sodium/iodide symporter Glioma Transfer Gene therapy
  • 相关文献

参考文献9

  • 1Sathomsumetee S, Rich JN. Antiangiogenic therapy in malignant glioma: promise and challenge [J]. Curt Pharm Des, 2007,13(35): 3545.
  • 2Hsieh YJ, Ke CC, Liu RS, et al. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter [J]. Anticaneer Res, 2007 , 27(4B): 2515.
  • 3Lee YJ,Chung JK,Shin JH, et al. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene [J]. Thyroid, 2004,14(11):889.
  • 4Petrich T, Knopp WH, Pfitter E. Functional activity of human sodium/iodide symporter in tumor cell Lines [J]. Nuklearmedizin, 2003, 42(1):15.
  • 5Spitaweg C, Morris JC. Gene therapy for thyroid cancer:, current status and future prospects [J]. Thyroid, 2004,14(6):424.
  • 6Dwyer RM, Bergert ER, O' Connor MK, et al. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors [J]. Hum Gene Ther, 2006,17(6):661.
  • 7Kogai T, Taki K, Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer [J]. Endocr Relat Cancer, 2006,13(3):797.
  • 8Kim H J, Jeon YH, Kang JH ,et al. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin c promoter [J]. Cancer Biol Ther, 2007,6(7).
  • 9Mandell RB, Mandell LZ, Link CJ Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene [J]. Cancer Res, 1999, 59(3):661.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部